Mind, Brain, and Drug: An Introduction to PsychopharmacologyCovering the basic principles of psychopharmacology, this textbook presents psychopharmacology and drugs of abuse in a readily understood manner. With all of the latest research and a straightforward, engaging writing style, Hedges offers complete coverage of the field without being unnecessarily detailed--and, as a result, provides students with a thorough introduction to this increasingly important area. |
From inside the book
Results 1-3 of 88
Page 55
... result in greater efficacy - the response versus dose curve becomes flat ( change in efficacy / change in dose = 0 ) . Key pharmacodynamic features are summarized in Table 3.2 . Dose - Response Curves Response versus drug dose can be ...
... result in greater efficacy - the response versus dose curve becomes flat ( change in efficacy / change in dose = 0 ) . Key pharmacodynamic features are summarized in Table 3.2 . Dose - Response Curves Response versus drug dose can be ...
Page 58
... result in a drop in carba- mazepine concentration ( Pippenger , 1987 ) with a potential for loss of therapeutic effects . To overcome this drop in concentration , the dose may be increased , restor- ing the original therapeutic effects ...
... result in a drop in carba- mazepine concentration ( Pippenger , 1987 ) with a potential for loss of therapeutic effects . To overcome this drop in concentration , the dose may be increased , restor- ing the original therapeutic effects ...
Page 291
... result in considerable adverse effects ( see Chapter 8 ) , but the relatively low affinity of memantine for these receptors appears to result in com- paratively few adverse effects . Memantine also may interact with nicotinic and ...
... result in considerable adverse effects ( see Chapter 8 ) , but the relatively low affinity of memantine for these receptors appears to result in com- paratively few adverse effects . Memantine also may interact with nicotinic and ...
Common terms and phrases
abnormalities abuse acetylcholine action potential addition ADHD adverse effects agonist alcohol Alzheimer's disease American Journal amphetamines antagonism anticonvulsant antidepressants anxiety disorder appears associated atypical antipsychotics axons barbiturates behavioral benzodiazepines bipolar disorder blood body brain bupropion buspirone caffeine cannabinoid cell Clinical Psychiatry clozapine cocaine cognitive concentrations cortex cytochrome P450 dementia dopamine dose Drug-Drug Interactions efficacy enzymes example factors fluoxetine function GABA ginkgo glutamate half-life hippocampal hyperactivity disorder increased inhibit insomnia involved John's wort Journal of Clinical Journal of Psychiatry kava lithium major depression marijuana mechanism of action medications metabolism methadone methylphenidate mirtazapine modafinil monoamine oxidase mood stabilizers nervous system neurobiology neurons Neuroscience neurotransmitter nicotine norepinephrine occur opiate opioid pain panic disorder patients Pharmacokinetics Pharmacology presynaptic Psychopharmacology psychosis result role schizophrenia seizure serotonin side effects social phobia SSRIs stimulation supplement symptoms synapse syndrome TCAs therapeutic therapy tion toxicity treatment typical antipsychotics valerian valproic acid venlafaxine withdrawal